Join now to get access to this content and more.
Become a SOAP member and have access to our benefits.
- For Review: SOAP Consensus Statement on Neuraxial Procedures in Thrombocytopenic Parturients
- Sample Centers of Excellence Applications
- ASA Corner
- SOAP Policy and Procedure Manual (P&P Manual)
- SOAP Expert Opinions
- SOAP's Learning Modules
- 2019 Annual Meeting Lecture Videos
- December 2018 - SOAP Unofficial Guide to ASA Committees Webinar
- Submit a Position
- View Job Postings
- Previous Meeting Archives
- Previous Meeting Abstract Search
- CMS Guidelines
- Member Benefits
- Newsletter Clinical Articles
- ACOG Documents
- Search our Patient Safety Archive
- Ask SOAP a Question
- Global Health Opportunities
- And more…
Developing and Testing an Objective Pain Measurement Device in Laboring Women
Abstract Number: T-07
Abstract Type: Original Research
Introduction: There are currently no reliable, commercially available, objective pain measurement devices. This study aimed to perform algorithm calibration and testing for a novel pain measurement device for labor pain and neuraxial analgesia evaluation.
Methods: 15 healthy pregnant women requesting epidural labor analgesia were enrolled in this IRB-approved, prospective cohort study. A non-invasive, adhesive sensor (Covidien NellcorTM) was placed on the subject’s forehead and connected to the pain measurement device in development (ROPAMedics, LLC). An independent investigator recorded timing and numerical rating pain scores (NRS) of contractions and other painful events. The study started at setup for epidural analgesia and ended with achievement of analgesia (NRS ≤2 with contractions). Patients received an epidural (5+5+5 ml 0.125% bupivacaine + sufentanil 10 mcg) or combined-spinal epidural (bupivacaine 2.5 mg + sufentanil 5 mcg). De-identified data was then used by ROPAMedics to calibrate an algorithm that calculates Real-Time Cerebral Hemodynamic Response (RTCHR). RTCHR is a measure of frontal lobe cortical activity, driven by regional changes in oxygenated and deoxygenated hemoglobin concentration, which has been shown to correlate with pain or nociception. Correlation analysis was performed using Spearman’s rank or Kendall-Tau, as appropriate, to assess the relationship between RTCHR recordings and patient-reported pain NRS.
Results: The study protocol was successfully applied to 15 laboring women. A representative patient dataset showing overlay of events during the study period, fetal heart rate, uterine contractions, and RTCHR measurements is shown in Fig 1A. The Kendall-Tau correlation coefficient between measured RTCHR and patient-reported pain NRS was strong and statistically significant (0.81, p<0.001;Fig 1B).
Discussion: An objective pain measurement device would be invaluable for patients who cannot verbalize pain scores, such as infants or sedated patients, or could complement subjective pain scores to prevent under or over treatment of pain. Laboring women receiving neuraxial analgesia provided an excellent study population for device algorithm development and calibration. Double-blinded studies to validate and further develop this novel pain measurement tool in obstetric and non-obstetric subjects are ongoing.
1. J Pain. 2009;10(10):1001-11
2. J Neurosci. 2006;26(14):3662-6